These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37101265)

  • 21. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.
    Nebreda-Mayoral T; Miguel-Gómez MA; March-Rosselló GA; Puente-Fuertes L; Cantón-Benito E; Martínez-García AM; Muñoz-Martín AB; Orduña-Domingo A
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Apr; 40(4):158-165. PubMed ID: 35216948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory bacterial co-infections in intensive care unit-hospitalized COVID-19 patients: Conventional culture vs BioFire FilmArray pneumonia Plus panel.
    Foschi C; Zignoli A; Gaibani P; Vocale C; Rossini G; Lafratta S; Liberatore A; Turello G; Lazzarotto T; Ambretti S
    J Microbiol Methods; 2021 Jul; 186():106259. PubMed ID: 34062210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards.
    Husain M; Valayer S; Poey N; Rondinaud E; d'Humières C; Visseaux B; Lariven S; Lescure FX; Deconinck L
    Infect Dis Now; 2022 Jun; 52(4):208-213. PubMed ID: 34896662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial Coinfections in Coronavirus Disease 2019.
    Westblade LF; Simon MS; Satlin MJ
    Trends Microbiol; 2021 Oct; 29(10):930-941. PubMed ID: 33934980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ).
    Rothe K; Spinner CD; Panning M; Pletz MW; Rohde G; Rupp J; Witzenrath M; Erber J; Eberhardt F; Essig A; Schneider J;
    Infection; 2021 Dec; 49(6):1299-1306. PubMed ID: 34687426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients.
    Teng F; Liu X; Guo SB; Li Z; Ji WQ; Zhang F; Zhu XM
    J Infect Chemother; 2019 Feb; 25(2):129-136. PubMed ID: 30448361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial Pneumonia and Respiratory Culture Utilization among Hospitalized Patients with and without COVID-19 in a New York City Hospital.
    Weidmann MD; Berry GJ; Zucker JE; Huang S; Sobieszczyk ME; Green DA
    J Clin Microbiol; 2022 Jul; 60(7):e0017422. PubMed ID: 35642519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
    Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
    Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.
    Sharifipour E; Shams S; Esmkhani M; Khodadadi J; Fotouhi-Ardakani R; Koohpaei A; Doosti Z; Ej Golzari S
    BMC Infect Dis; 2020 Sep; 20(1):646. PubMed ID: 32873235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit.
    Yang S; Hua M; Liu X; Du C; Pu L; Xiang P; Wang L; Liu J
    Microbes Infect; 2021; 23(4-5):104806. PubMed ID: 33684520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of community-acquired atypical bacterial pneumonia among adult COVID-19 patients from a single center in Al Madinah Al Munawarah, Saudi Arabia: A retrospective cohort study.
    Alhoufie ST; Ibrahim NA; Alsharif NH; Alfarouk KO; Makhdoom HM; Aljabri KR; Saeed SH; Khoumaeys AA; Almutawif YA; Najim MA; Ali HM; Aljifri AA; Kheyami AM; Alhazmi AA
    Saudi Med J; 2022 Sep; 43(9):1000-1006. PubMed ID: 36104051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
    Lai CC; Wang CY; Hsueh PR
    J Microbiol Immunol Infect; 2020 Aug; 53(4):505-512. PubMed ID: 32482366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What happened during COVID-19 in African ICUs? An observational study of pulmonary co-infections, superinfections, and mortality in Morocco.
    Aissaoui Y; Ennassimi Y; Myatt I; El Bouhiaoui M; Nabil M; Bahi M; Arsalane L; Miloudi M; Belhadj A
    PLoS One; 2022; 17(12):e0278175. PubMed ID: 36454978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
    Liu HH; Yaron D; Piraino AS; Kapelusznik L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: impact of gram-negative bacterial resistance.
    Costa RLD; Lamas CDC; Simvoulidis LFN; Espanha CA; Moreira LPM; Bonancim RAB; Weber JVLA; Ramos MRF; Silva ECF; Oliveira LP
    Rev Inst Med Trop Sao Paulo; 2022; 64():e6. PubMed ID: 35137900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature.
    Frutos MC; Origlia J; Gallo Vaulet ML; Venuta ME; García MG; Armitano R; Cipolla L; Madariaga MJ; Cuffini C; Cadario ME;
    Rev Argent Microbiol; 2022; 54(3):247-257. PubMed ID: 35931565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.